City Therapeutics Appoints Keith Regnante as Chief Financial Officer and Mary Beth DeLena as Chief Legal Officer
Position
Chief Legal Officer
Company
City Therapeutics
Description
City Therapeutics, Inc. announced the appointments of Keith Regnante as Chief Financial Officer and Mary Beth DeLena as Chief Legal Officer. Mr
Other recent leadership changes in Therapeutics and Biotechnology
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Kalohexis Appoints Jeffrey Sherman as Chief Medical Officer (August 11, 2026)
- EIT Pharma Appoints Dr. Leen Kawas as Chief Executive Officer (August 12, 2026)
- Innate Pharma Appoints Markus Jensen as Chief Medical Officer (August 10, 2026)
- Percheron Therapeutics Appoints Michael Baker as Chief Executive Officer (August 10, 2026)
- Olema Pharmaceuticals Appoints Jason O’Byrne as Chief Financial Officer (August 13, 2026)
- Olema Oncology Appoints Jason O’Byrne as Chief Financial Officer (August 14, 2026)
Who to call at City Therapeutics, and when
A new leader at City Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day City Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at City Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at City Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment City Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
City Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.